Protagonist Therapeutics Inc (PTGX) Event Aug. 04, 2022, 00:00 UTC (76% Positive) PROTAGONIST THERAPEUTICS, INC. (PTGX) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 12:18 p.m. 🏢 Protagonist Therapeutics Inc (PTGX) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-54.84M $-61.97M $7.13M +11.50% 📉 Total Assets $347.69M $310.51M $37.18M +11.97% 📈 Total Liabilities $47.67M $42.53M $5.14M +12.08% 📉 Stockholders' Equity $357.45M $-338.65M $696.10M +205.55% 📈 Operating Income/Loss $-54.90M $-62.55M $7.65M +12.23% 📉 R&D Expense N/A N/A N/A +0.00% ➡️ Earningspersharebasic $-1.23 $-1.27 $0.04 +3.15% ➡️ Earningspersharediluted $-1.23 $-1.27 $0.04 +3.15% ➡️ 📈 Financial Trend Analysis 🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Protagonist Therapeutics Inc (PTGX) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document